MinusSugar

Cycles Nutrition offers evidence-based nutritional solutions that help individuals who care about their health improve their longevity and overall quality of life.

AIPER creates environmentally friendly pigments from agricultural waste using fermentation for the textile and cosmetics sectors. It suggests making biodegradable pigments from microbes as a sustainable option to harmful chemicals used in the industry, which helps clients reduce negative effects on water sources and the environment.

Future Cow is an innovative startup in Brazil that specializes in cellular agriculture. Their groundbreaking technology produces dairy milk that is identical to cow milk, but without any cows being involved. Instead, they use advanced fermentation techniques to replicate the molecular proteins found in cow milk using a digitized copy of the cow gene, without taking any animal cells. This animal-free milk has far less of an environmental impact than traditional dairy, and it also addresses concerns around animal welfare. Additionally, this technology has the potential to disrupt the dairy industry by offering consumers a more ethical, sustainable, and delicious alternative to traditional dairy. Overall, Future Cow is excited to be at the intersection of science and food, developing technology that has the potential to change the way we think about dairy products.

Decoy Smart Control is biological solutions developer for pest control.

LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines. LifeMine’s Avatar-Rx platform integrates high-throughput microbiology, data science and machine learning, genome engineering, and automation technologies to search the fungal biosphere for novel GEMs having a predetermined target and biological function. The platform integrates chemoinformatic-assisted drug optimization and state-of-the-art chemical synthesis with biotransformation to advance new product candidates into development. Founded by Gregory Verdine, PhD, Rick Klausner, MD, and WeiQing Zhou, MBA. LifeMine Therapeutics is headquartered in Cambridge, Massachusetts.

Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential of functional molecular mimics. The MIMiCTM platform, developed by the business, is a computationally driven bio platform for developing novel therapies in which function, specificity, and selectivity may be optimized. Metaphore is dedicated to uncovering previously inaccessible pharmacological targets and achieving breakthroughs that exceed today's medications for maximum patient effect.

BRAINBox provides objective evidence of injury and prediction of patient recovery. BRAINBox Solutions' multi-modality approach is led by the leaders in the industry. It includes blood biomarker panels available on a point of care instrument and standard laboratory systems.

CND Life Sciences is committed to supporting patients with neurodegenerative diseases, offering the Syn-One Test® as a first-of-its-kind tool to detect and measure misfolded phosphorylated alpha-synuclein in cutaneous nerve fibers. This test helps confirm synucleinopathies like Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and pure autonomic failure. The company operates a CLIA-certified and CAP-accredited lab in Scottsdale, AZ, providing a convenient and accurate alternative for diagnosis through skin biopsies. Additionally, CND collaborates with biopharmaceutical companies to advance research in the field.

Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.

Dash Bio is a cutting-edge platform that employs AI, robotics, and fully integrated software to revolutionize the process of drug development and bring new medications to market.

Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications.

Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making. It revolutionizes the way genetic diagnoses and discoveries are made. The company’s suite of diagnostic and discovery tools enable physicians, pharma, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. It was founded in 2014 and is headquartered in Ann Arbor, Michigan.